دورية أكاديمية

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

التفاصيل البيبلوغرافية
العنوان: Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
المؤلفون: Li, Jing-Xin, Wu, Shi-Po, Guo, Xi-Ling, Tang, Rong, Huang, Bao-Ying, Chen, Xiao-Qin, Chen, Yin, Hou, Li-Hua, Liu, Jing-Xian, Zhong, Jin, Pan, Hong-Xing, Shi, Feng-Juan, Xu, Xiao-Yu, Li, Zhuo-Pei, Zhang, Xiao-Yin, Cui, Lun-Biao, Tan, Wen-Jie, Chen, Wei, Zhu, Feng-Cai, Huang, Hai-Tao, Gou, Jin-Bo, Si, Wei-Xue, Wang, Xue, Zhao, Xiao-Long, Zhu, Tao
المصدر: In The Lancet Respiratory Medicine August 2022 10(8):739-748
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22132600
DOI:10.1016/S2213-2600(22)00087-X